The nation’s first comprehensive look at the impact of reduced optometry services due to the COVID-19 lockdown has been provided in new Specsavers data. Australia and New Zealand optometry director Dr BENJAMIN ASHBY delves into the statistics and outlines a plan to manage the patient backlog.
A Dutch court has dismissed a EssilorLuxottica court case demanding that its potential takeover target Grandvision disclose information over the way it conducted business during COVID-19, leaving the door open for an appeal. Read more
A Melbourne-based drug company is one step closer to starting Phase 3 clinical trials and pre-commercial development of its novel treatment for neovascular age-related macular degeneration (nAMD). Read more
Bausch + Lomb has obtained regulatory approval to supply its new Ultra One Day daily disposable silicone hydrogel (SiHy daily) contact lenses in Australia. Read more
A biopharmaceutical company that is developing cheaper anti-VEGF treatments for Australia and other markets has launched a global clinical trial for a biosimilar version of leading treatment Eylea (aflibercept). Read more
Melbourne-based OCT manufacturer Cylite has obtained certification to carry the iconic Australian Made mark. Read more
US tech giant Apple has filed a patent for a new head mounted device (HMD) that it claims can correct vision electronically when the device is worn. Read more
Broken spectacle replacements, essential OrthoK reviews, foreign bodies and intravitreal injections feature among the most necessary services Melbourne eyecare professionals are providing one week on from hardened lockdown restrictions. Read more
Following the COVID-19 peak, Insight issued a sentiment survey to understand the eyecare sector’s views on topics ranging from the government’s crisis response to industry confidence. Here, we reveal the findings and talk to business owners about their experiences. Read more
Eleven Australian and five New Zealand Specsavers stores have been named as finalists for the annual Doug Perkins Medal. Read more